Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported):  November 15, 2010
 
STAAR Surgical Company
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction
of incorporation)
0-11634
(Commission File Number)
95-3797439
(I.R.S. Employer
Identification No.)
     
1911 Walker Ave, Monrovia, California
(Address of principal executive offices)
  
91016
(Zip Code)

Registrant’s telephone number, including area code:        626-303-7902
 
                                    Not Applicable                                    
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.
 
On November 15, 2010, the Board of Directors of STAAR Surgical Company elected Mark B. Logan to the Board, to serve in a newly created seat pursuant to an increase in size of the Board from six to seven members.

The Board has determined that Mr. Logan is an independent director as that term is defined under the Nasdaq Marketplace Rules and the applicable rules of the SEC. The committees of the Board on which Mr. Logan may serve, if any, have not been determined at the time of this Report.

The appointment of Mr. Logan to the Board was not the result of any arrangement or understanding between Mr. Logan and any other person or entity. There are no transactions between Mr. Logan or any member of his immediate family and the Company or any of its subsidiaries.
 
Item 7.01
Regulation FD Disclosure.
 
On November 17, 2010, STAAR Surgical Company published a press release announcing the appointment of Mark B. Logan to its Board of Directors, a copy of which is furnished as Exhibit 99.1 to this Report.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
November 22, 2010
STAAR Surgical Company
  
       
 
By:
/s/ Charles Kaufman
  
   
Charles Kaufman
Vice President and General Counsel
 
 
 
 
 
EXHIBIT INDEX
 
Exhibit No.
Description
   
99.1 Press release dated November 17, 2010.